Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis - PubMed
Review
Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis
Sankar D Navaneethan et al. Clin J Am Soc Nephrol. 2009 Oct.
Abstract
Background and objectives: Obesity is an independent risk factor for development and progression of chronic kidney disease (CKD). We conducted a systematic review to assess the benefits of intentional weight loss in patients with non-dialysis-dependent CKD and glomerular hyperfiltration.
Design, setting, participants, & measurements: We searched MEDLINE, SCOPUS, and conference proceedings for randomized, controlled trials and observational studies that examined various surgical and nonsurgical interventions (diet, exercise, and/or antiobesity agents) in adult patients with CKD. Results were summarized using random-effects model.
Results: Thirteen studies were included. In patients with CKD, body mass index (BMI) decreased significantly (weighted mean difference [WMD] -3.67 kg/m(2); 95% confidence interval [CI] -6.56 to -0.78) at the end of the study period with nonsurgical interventions. This was associated with a significant decrease in proteinuria (WMD -1.31 g/24 h; 95% CI -2.11 to -0.51) and systolic BP with no further decrease in GFR during a mean follow-up of 7.4 mo. In morbidly obese individuals (BMI >40 kg/m(2)) with glomerular hyperfiltration (GFR >125 ml/min), surgical interventions decreased BMI, which resulted in a decrease in GFR (WMD -25.56 ml/min; 95% CI -36.23 to -14.89), albuminuria, and systolic BP.
Conclusions: In smaller, short-duration studies in patients with CKD, nonsurgical weight loss interventions reduce proteinuria and BP and seem to prevent further decline in renal function. In morbidly obese individuals with glomerular hyperfiltration, surgical interventions normalize GFR and reduce BP and microalbuminuria. Larger, long-term studies to analyze renal outcomes such as development of ESRD are needed.
Figures

Flow chart showing number of citations retrieved by individual searches and number of trials included in the review.

Effect of nonsurgical interventions on GFR in CKD.

Effect of nonsurgical interventions on urinary protein excretion in CKD.

Effect of surgical interventions on glomerular hyperfiltration.
Similar articles
-
Effects of weight loss on renal function in obese CKD patients: a systematic review.
Bolignano D, Zoccali C. Bolignano D, et al. Nephrol Dial Transplant. 2013 Nov;28 Suppl 4:iv82-98. doi: 10.1093/ndt/gft302. Epub 2013 Oct 2. Nephrol Dial Transplant. 2013. PMID: 24092846 Review.
-
Weight loss: a neglected intervention in the management of chronic kidney disease.
Ibrahim HN, Weber ML. Ibrahim HN, et al. Curr Opin Nephrol Hypertens. 2010 Nov;19(6):534-8. doi: 10.1097/MNH.0b013e32833f13de. Curr Opin Nephrol Hypertens. 2010. PMID: 20827193 Review.
-
Navaneethan SD, Nigwekar SU, Sehgal AR, Strippoli GF. Navaneethan SD, et al. Clin J Am Soc Nephrol. 2009 Mar;4(3):542-51. doi: 10.2215/CJN.04750908. Epub 2009 Mar 4. Clin J Am Soc Nephrol. 2009. PMID: 19261819 Free PMC article. Review.
-
Othman M, Kawar B, El Nahas AM. Othman M, et al. Nephron Clin Pract. 2009;113(1):c16-23. doi: 10.1159/000228071. Epub 2009 Jul 10. Nephron Clin Pract. 2009. PMID: 19590231
-
Li K, Zou J, Ye Z, Di J, Han X, Zhang H, Liu W, Ren Q, Zhang P. Li K, et al. PLoS One. 2016 Oct 4;11(10):e0163907. doi: 10.1371/journal.pone.0163907. eCollection 2016. PLoS One. 2016. PMID: 27701452 Free PMC article. Review.
Cited by
-
Kurnik Mesarič K, Kodrič J, Logar Zakrajšek B, Pernat AM, Bogataj Š, Pajek J. Kurnik Mesarič K, et al. Contemp Clin Trials Commun. 2023 Nov 21;36:101236. doi: 10.1016/j.conctc.2023.101236. eCollection 2023 Dec. Contemp Clin Trials Commun. 2023. PMID: 38074489 Free PMC article.
-
Obesity and renal disease: Benefits of bariatric surgery.
Ardiles LG. Ardiles LG. Front Med (Lausanne). 2023 Feb 28;10:1134644. doi: 10.3389/fmed.2023.1134644. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36926320 Free PMC article. Review.
-
Segar MW, Kolkailah AA, Frederich R, Pong A, Cannon CP, Cosentino F, Dagogo-Jack S, McGuire DK, Pratley RE, Liu CC, Maldonado M, Liu J, Cater NB, Pandey A, Cherney DZI. Segar MW, et al. Diabetes Obes Metab. 2022 Sep;24(9):1829-1839. doi: 10.1111/dom.14769. Epub 2022 Jun 15. Diabetes Obes Metab. 2022. PMID: 35603908 Free PMC article. Clinical Trial.
-
Nishiwaki H, Hasegawa T, Shinji M, Matsuo F, Watanabe T, Makino H, Koiwa F, Hishida A. Nishiwaki H, et al. Clin Exp Nephrol. 2018 Oct;22(5):1108-1115. doi: 10.1007/s10157-018-1562-6. Epub 2018 Mar 19. Clin Exp Nephrol. 2018. PMID: 29556893 Free PMC article.
-
Management of Hypertension in Chronic Kidney Disease.
Pugh D, Gallacher PJ, Dhaun N. Pugh D, et al. Drugs. 2019 Mar;79(4):365-379. doi: 10.1007/s40265-019-1064-1. Drugs. 2019. PMID: 30758803 Free PMC article. Review.
References
-
- Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM: Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 295: 1549– 1555, 2006 - PubMed
-
- Hu FB, Willett WC, Li T, Stampfer MJ, Colditz GA, Manson JE: Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med 351: 2694– 2703, 2004 - PubMed
-
- Yan LL, Daviglus ML, Liu K, Stamler J, Wang R, Pirzada A, Garside DB, Dyer AR, Van Horn L, Liao Y, Fries JF, Greenland P: Midlife body mass index and hospitalization and mortality in older age. JAMA 295: 190– 198, 2006 - PubMed
-
- Colditz GA, Willett WC, Rotnitzky A, Manson JE: Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 122: 481, 1995 - PubMed
-
- Garrison RJ, Kannel WB, Stokes J, 3rd, Castelli WP: Incidence and precursors of hypertension in young adults: The Framingham Offspring Study. Prev Med 16: 235– 251, 1987 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical